The Medicines Company (MDCO) Reports Q3 Loss of $0.25; Raises FY08 Sales Outlook, Cuts EPS Guidance
Tweet Send to a Friend
The Medicines Company (NASDAQ: MDCO) reports a Q3 loss of $0.25, which does not compare to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
